miophthalmology products

Ophthalmopro describes the new eyePlate-S as the next step forward in glaucoma drainage technology. Building on the trusted eyePlate platform, this new device combines a microsized tube with an optimised, ultra-thin silicone plate to give surgeons greater versatility and patients better outcomes.

The tube’s small external diameter allows entry via a 25G needle, while its narrow lumen supports precise flow control and helps reduce the risk of post-operative hypotony. At just 0.8 mm thick, the flexible plate can be folded for smoother insertion through a smaller incision, and its design maximises drainage without needing placement under the rectus muscles – lowering diplopia risk.

Available in two sizes (200 mm² and 300 mm²), the eyePlate-S is compatible with minimally invasive tube surgery, with procedures achievable in around 20 minutes.

Contact: Ophthalmopro (AUS) 1300 578 288 or (NZ) 0800 578 288

With more patients suffering posterior capsular opacification (PCO) following cataract surgery, and with newer generations of intraocular lenses (IOLs), higher precision is required to perform posterior capsulotomy.

With mode-specific mirror positioning and true coaxial illumination, Ellex’s second-generation Reflex design allows for titratable illumination from full,
to partial or no red-reflex, giving complete spatial integrity and excellent contrast of the posterior capsule and other important ocular structures.

The Tango Reflex Neo offers leading-edge YAG laser technology, delivering a four nanosecond ultra-Gaussian pulse at high peak power – achieving the industry’s lowest optical breakdown energy at 1.4mJ in air.* Performing capsulotomy at lower, more efficient energy levels, the Tango Reflex Neo enables a perfectly centred, and precise capsulotomy – a safe and highly effective treatment option for all types of IOLs while achieving successful patient outcomes.

Contact: Ellex salesadmin@ellex.com
* Based on system testing (data on file).

Bausch + Lomb offers a comprehensive cataract surgery portfolio, combining advanced surgical technology with innovative intraocular lenses. The Stellaris Elite Vision Enhancement System features adaptive fluidics, unique ultrasound energy management, and the new BiBlade+ VR cutter, delivering efficient lens removal, excellent chamber stability, and enhanced surgical control.

Complementing the platform, the enVista family of IOLs, including the premium enVista Envy full range of vision and enVista Aspire intermediate optimised IOLs, are designed to provide stable, predictable visual outcomes. Featuring StableFlex technology, SureEdge design, and AccuSet haptics, the enVista platform supports refractive precision, rotational stability, and long-term visual performance, helping surgeons deliver excellent outcomes for cataract patients.

Contact: Bausch + Lomb (AUS) 1800 251 150 or Customer.Service@bausch.com

Approximately 20% of cataract patients also have glaucoma or ocular hypertension. When cataract and glaucoma coexist, patients often seek care for cloudy vision from cataracts, while gradual vision loss from glaucoma may go unnoticed until advanced stages.

To determine if glaucoma affects a patient’s vision improvement expectations and long-term vision related quality of life, it’s essential to identify the glaucoma type, disease stage, and establish an appropriate treatment plan.

ZEISS Glaucoma Workflow provides end-to-end solutions for diagnosing, monitoring, and treating glaucoma, including laser therapy and surgical options. The associated ZEISS Cataract Workflow supports improved outcomes for patients with both conditions.

Visit: zeiss.ly/gccp-1

Cataract and refractive lens exchange patients are educated and have high expectations. There are several situations where a 1stQ AddOn secondary supplementary sulcus lens may be required to achieve the best outcome.

The 1stQ AddOn lenses (Medicontur Group) have very high rotational stability in the sulcus due to the non-torque four-point fixation design. Available in monofocal, monofocal toric, trifocal, and trifocal toric options, these lenses allow precise correction of residual spherical and astigmatic refractive errors via the 0.25 D sphere equivalent steps and up to 11.0 D cylinder powers. Reversibility of trifocality is possible at any time via the dual lens procedure or trifocal upgrade, which provides a ‘get out of jail free’ card, in the event that the trifocal component becomes inappropriate.

Contact: SurgiVision (AUS) 1300 995 132 or (NZ) 02 8999 3323

The RxSight Light Adjustable Lens (LAL) is the first and only intraocular lens that enables postoperative refractive customisation. Using targeted UV light treatments after surgery, the non-diffractive lens can be adjusted to refine refractive outcomes while preserving contrast sensitivity and minimising dysphotopsias.
The LAL is designed to deliver laser-assisted in situ keratomileusis-like visual outcomes1,2 and is well suited to patients who have previously undergone refractive surgery.3 It also enables precise blended vision outcomes, is available in spherical powers from
-2.0 D to 30.0 D, and can correct as little as 0.5 D of astigmatism. In a bilateral implantation study,4 93% of patients achieved uncorrected distance vision of 6/6 or better, while 94% achieved J2 (N6) near vision or better at best focus.

Contact: RxSight contact_globalmarketing@rxsight.com

Oertli’s surgical platforms are designed to support ophthalmic surgeons, particularly vitreoretinal specialists, by enhancing their surgical experience. The OS 4 system offers a versatile solution for posterior segment surgery, featuring a multi-pump fluidics system with proprietary SPEEP (speed and precision) function and optional integrated laser and illumination options. Its design supports efficient workflow and precise control during delicate procedures. To expand on these possibilities, the Faros system balances portability with advanced dual-pump functionality at a low cost. The CataRhex 3 provides a compact alternative for cataracts, for mobile or space-limited environments.

Contact: Device Technologies Account Manager or eyes@device.com.au

iStent infinite is intended to reduce intraocular pressure (IOP) safely and effectively in adult patients diagnosed with open-angle glaucoma.

iStent infinite contains three tiny titanium stents, preloaded in an injector system which are designed to:

• Deliver foundational, 24/7, long-term control of IOP in patients with glaucoma, including those who have failed prior medical and surgical intervention.1

• Safely offer interventional glaucoma, a truly micro-invasive alternative to medications and more invasive procedures.

• Restore physiologic outflow by creating arcs of flow spanning up to eight clock hours (240°) while minimising tissue disruption.1

• Provide the versatility to treat a variety of patients in combination with cataract surgery or as a standalone procedure.

Visit: glaukos.net.au

Heidelberg Engineering brings high-resolution imaging to glaucoma and cataract workflows. Spectralis remains the trusted standard for glaucoma monitoring, with retinal nerve fibre layer and ganglion cell layer analysis combined with AutoRescan for reliable progression detection. Anterion extends this legacy to the anterior segment, using swept-source optical coherence tomography for corneal tomography, topography, wavefront, and biometry.

The result: precise premium intraocular lens calculations, implantable collamer lens sizing, and accurate ectasia screening, alongside anterior chamber angle assessment and visualisation of lens and posterior capsule status, and minimally invasive glaucoma surgery (MIGS) device positioning, all from a single device.

This year, Heidelberg Opera joins the family: a fully digital surgical microscope. Together, Spectralis, Anterion, and Opera will deliver advanced imaging to plan, operate, and monitor with confidence.

Contact: Heidelberg Engineering Australia (AUS) 03 9639 2125 or info-au@heidelbergengineering.com

TrabEx Pro is an innovative dual-blade excisional goniotomy device designed to support controlled partial excision of the trabecular meshwork during minimally invasive glaucoma surgery procedures.

Featuring dual serrated trapezoidal blades, TrabEx Pro enables precise tissue excision, and integrates active irrigation and aspiration through connection to a phaco machine. This helps maintain chamber stability and clear visualisation throughout the procedure.

A rounded footplate accommodates varying patient anatomies, and a flexible silicone sleeve supports compatibility with 2.2–2.4 mm incisions. The sterile, single-use design promotes procedural efficiency and consistency, providing surgeons with an intelligent solution for trabecular meshwork excision in glaucoma surgery.

Visit: iqmedical.com.au or contact (AUS) 08 8357 8022

Miniject is iSTAR Medical’s innovative minimally invasive glaucoma surgery device for patients with open-angle glaucoma. Miniject combines the distinctive porous structure of its proprietary Star material with the power offered by the supraciliary space. As a result, it is designed to enhance physiological fluid outflow, reducing intraocular pressure (IOP) and the need for medication, while bio-integrating with surrounding tissue, limiting inflammation, fibrosis, and subsequent complications.

Five-year follow-up results demonstrate sustained, meaningful, mean IOP reduction of 38% to 14.8 mmHg, with 85% of patients using the same or fewer medications. In addition, 55.3% of patients had IOP≤15 mmHg and 83% of patients achieved ≥20% IOP reduction from baseline at five-year follow up.1

Visit: istar-medical.com

Pattern microsecond laser trabeculoplasty (PMLT), first performed in Europe by Dr Davide Borroni, is a new laser treatment for ocular hypertension and open-angle glaucoma. Developed by Danish company Norlase on its Echo laser platform, PMLT is an evolution of micropulse laser trabeculoplasty, designed to lower intraocular pressure (IOP) while minimising tissue damage and post-treatment inflammation.

The technology uses digitally guided microsecond laser pulses that align precisely with the trabecular meshwork, allowing automated spot placement, improving treatment accuracy, and reducing procedure time. According to Dr Borroni, the system’s guidance and automation help ensure complete coverage without overlapping laser spots.

In an initial patient treated in Italy, PMLT enabled discontinuation of pressure-lowering eye drops, resolving medication-related ocular irritation. The in-office procedure takes about three minutes per eye and has achieved an approximately 18% reduction in IOP at one month. Early clinical experience suggests PMLT could become an important first-line treatment option for ocular hypertension.

Visit: optopol.au/contact

The Paul Glaucoma Implant is made of the highest grade of medical implantable silicone with innovative design features to deliver efficacy and safety.

It’s micro-sized tube design delivers the smallest inner diameter safeguarding against early hypotony, and outer diameter minimising the risk of tube erosion and corneal touch. Plate dimensions are optimised to achieve better filtration and drainage to control intraocular pressure and reduce the need for post-op medication.

Contact: ParagonCare vision@paragoncare.com.au or scan the QR code.

The Fox IV 810 from ARC Laser is a versatile 810 nm diode laser designed to support modern glaucoma management. Offering both conventional cyclophotocoagulation (CPC) and microsecond cyclophotocoagulation (μCPC), it delivers targeted treatment of the ciliary body to reduce aqueous humour production and effectively lower intraocular pressure.

Beyond glaucoma, the Fox IV 810 supports retinal photocoagulation and lacrimal surgical applications, providing exceptional clinical flexibility. Its compact, portable design, intuitive touchscreen interface, and proven German engineering make it ideal for consulting rooms, procedure suites, and operating theatres. Combining precision, versatility, and reliable performance, the Fox IV 810 is a trusted solution for contemporary ophthalmic practice.

Visit: spectrumsurgical.com.au or contact sales@spectrumsurgicalcom.au

Optos helps clinicians see more, know more, and do more, with confidence. Using optomap ultra-widefield retinal imaging, Optos devices capture up to 200° of the retina in a single image – helping support efficient assessment, patient education, and ongoing disease management. For cataract patients, optomap provides a clear view of the peripheral retina before surgery, helping identify pathology that may otherwise go undetected, and supporting more informed surgical planning.

In glaucoma management, ultra-widefield imaging can assist clinicians in documenting retinal pathology and monitoring patients over time, as part of a comprehensive eye care approach. The California RGB device delivers high-quality colour retinal images with exceptional clarity, enabling detailed visualisation and supporting fast, comfortable imaging for both clinicians and patients.

Visit: optos.com or contact (AUS) 08 8444 6500

RayOne Galaxy, a next-generation spiral intraocular lens (IOL) platform from Rayner, has been meticulously engineered to redefine the way your presbyopia patients experience the world. A proprietary artificial intelligence engine created the RayOne Galaxy’s unique optical spiral, which is tuned for optimised visual acuity, a smooth and continuous full range of vision, and minimised dysphotopsia.

The RayOne Galaxy boasts a revolutionary spiral optic that delivers a full range of vision with an exceptionally smooth transition from distance to near. The non-diffractive spiral design avoids abrupt transitions in the lens’ surface, reducing dysphotopsia and light loss.

Compared to a trifocal IOL, the RayOne Galaxy shows:
• No surface steps or discontinuities.
• No discrete annular zones.
• A smooth optic surface.

Visit: rayner.com/global/en/iol/galaxy or contact (AUS) 1300 RAYNER (1300 728 637)

A new range of intraocular lenses (IOLs), exclusively distributed in Australia by IQ Medical, spans presbyopia-correcting, extended depth of focus (EDOF) and monofocal technologies. The IQ Medical IOL portfolio brings together lenses from Ophtec and AST Visioncare.

Within the presbyopia-correcting range is Ophtec’s Precizon Presbyopic, a hybrid acrylic lens built around the company’s patented Continuous Transitional Focus (CTF) technology. The purely refractive design uses multiple segments across the lens’ anterior surface to deliver a smooth, continuous transition of power from distance to near, with the aim of helping patients achieve spectacle independence.

For patients seeking enhanced intermediate vision without the trade-offs associated with advanced optics,

Ophtec’s Precizon Go offers a true non-diffractive monofocal plus design, preserving distance clarity while extending functional focus for everyday tasks.

AST Visioncare’s contribution includes the Asqelio Trifocal and Asqelio EDOF lenses, both built on the hydrophobic acrylic MBI platform. The Asqelio Trifocal is positioned to deliver freedom from glasses across a continuous visual range, with optimised energy distribution between intermediate and near focal points designed to minimise the visual disturbances often associated with multifocal lenses. The Asqelio EDOF, meanwhile, uses wavefront-shaping technology and a bi-aspheric optic to elongate the focal range, providing excellent distance and intermediate vision while maintaining high optical quality and a low incidence of photic phenomena. According to IQ Medical, many patients also achieve functional near vision without spectacles.

Rounding out the portfolio is PreciSAL, a monofocal designed for surgeons who demand precise refractive targeting. Manufactured to a 0.125 D tolerance and available in 0.25 D increments, the platform combines exceptional manufacturing precision with a glistening-free, tray-polymerised lathe-cut optic. The toric design incorporates AccuPlace quadrant lathing to enhance rotational tolerance and support predictable astigmatism correction.

All lenses, including toric models, are supplied in preloaded delivery systems to support efficient and consistent implantation.

Each lens in the collection is supplied with a preloaded injector system – IOLMatic, Pioli or Accuject, depending on the model – to support ease of implantation in theatre.

Visit: iqmedical.com.au